https://www.live-feeds.com/feed/pfizer-ceo-touts-80-billion-in-dealsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/pfizer-ceo-touts-80-billion-in-dealshttps://www.live-feeds.com/feed/pfizer-ceo-touts-80-billion-in-deals#u188344Mon, 09 Nov 2026 16:30:25 +0000Pfizer raised its full-year financial outlook on Tuesday after beating third-quarter expectations, driven by momentum in newer products and solid demand for its blood thinner drug. Chief Executive Officer Albert Bourla also highlighted eighty billion dollars in corporate deals, while the company named a corporate veteran as its new chief financial officer. The positive earnings report extends a broader windfall for big pharma, even as sales for COVID-19 treatments continue to decline across the sector.Why it mattersThe pharmaceutical giant relies on strong performance from newer drugs and key